J. Goldman & Co’s Gossamer Bio GOSS Stock Holding History

J. Goldman & Co’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-58,403	Closed	-$507K	–	401
2022 Q1	$507K	Buy	+58,403	New	+$563K	0.02%	287

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

J. Goldman & Co's GOSS Position: Q2 2022 in Review

J. Goldman & Co sold out of Gossamer Bio (GOSS) in Q2 2022, closing a stake of 58,403 shares — an estimated $507K sold.

J. Goldman & Co first reported a position in GOSS in Q1 2022 and held it in 1 quarter. The position peaked at $507K in Q1 2022. 129 funds tracked by Wall St. Rank hold GOSS as of Q2 2022.

J. Goldman & Co reported no remaining Gossamer Bio position as of Q2 2022 after selling out during the quarter.
J. Goldman & Co sold 58,403 Gossamer Bio shares in Q2 2022, an estimated $507K.
J. Goldman & Co first reported a position in Gossamer Bio in Q1 2022 and held it in 1 quarter.
J. Goldman & Co's Gossamer Bio position peaked at $507K in Q1 2022.
129 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2022.

Based on J. Goldman & Co's 13F filing for Q2 2022, filed 15 Aug 2022.